Novel kinetics, behaviour and cell-type specificity of CD157-mediated tyrosine kinase signalling

Cellular Signalling

Volumn 11, Issue 12, 1999, Pages 891-897

  Hussain, Alamgir M M ^a   Chang, Chan Fong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

BST 1; CD157; Cell proliferation; Ligand; Receptor; Tyrosine phosphorylation

Indexed keywords

CD 157 ANTIGEN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADP-RIBOSYL CYCLASE; ANIMALS; ANTIGENS, CD; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; DNA, COMPLEMENTARY; FIBROSARCOMA; GLYCOSYLPHOSPHATIDYLINOSITOLS; HL-60 CELLS; HUMANS; KINETICS; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS;

EID: 0032763713     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(99)00057-1     Document Type: Article

References (30)

1. Kaisho T., Ishikawa J., Oration K., Inazawa J., Tomizawa H., Muraoka O., Ochi T., Hirano T. Proc. Natl. Acad. Sci. USA. 91:1994;5325-5329.
2. Itoh M., Ishihara K., Tomizawa H., Tanaka H., Kobune Y., Ishikawa J., Kaisho T., Hirano T. Biochem. Biophys. Res. Commun. 203:1994;1309-1317.
3. Dong C., Wang J., Neame P., Cooper M.D. Int. Immunol. 6:1994;1353-1360.
4. Ishihara K., Okuyama Y., Lee B.O., Itoh M., Nishikawa K., Horano T. CD157 (BST-1) Workshop panel report. Kashimoto T., Kitutani H., von dem Borne A.E., Goyert S.M., Mason D.Y., Miyasaka M., Moretta L.et al. In. Leukocyte Typing VI:1997;1086-1089 Gerland Publishing, New York.
5. Howard M., Grimaldi J.C., Bazan J.F., Lund F.E., Santos A.L., Parkhouse R.M., Walseth T.F., Lee H.C. Science. 262:1993;1056-1059.
6. Hirata Y., Kimura N., Sato K., Ohsugi Y., Takasawa S., Okamoto H., Ishikawa J., Kaisho T., Ishihara K., Hirano T. FEBS Lett. 356:1994;244-248.
7. Lee H.C., Aarhus R., Walseth T.F. Science. 261:1993;352-355.
8. Takasawa S., Nata K., Yonekura H., Okamoto H. Science. 259:1993;370-373.
9. Shimaoka Y., Attrep J.F., Hirano T., Ishihara K., Suzuki R., Toyosaki T., Ochi T., Lipsky P.E. J. Clin. Invest. 102:1998;606-618.
10. M24.1. Influence of myeloid blind panel mAb on neutrophil transmigration across intestinal epithelial monolayers. Colgan S. P., Parkos C. A., Bacarra A. E. and Madara J. L., pp. 993-994. M24.4. Myeloid blind panel mAb activate the NADPH oxidase pathway and alter triggering through high-affinity IgG-Fc receptors. Pfefferforn C. L. and Sylvester M. D., pp. 999-1001. M24.5. The effects of myeloid blind panel mAb on polymorphonuclear leukocyte phagocytosis. Malinowska I. and Buescher E. S., pp. 1001-1004. In: Leukocyte Typing V (Todd III R. F., Ed), 1995. Oxford University Press, Oxford.
11. M24.1. Influence of myeloid blind panel mAb on neutrophil transmigration across intestinal epithelial monolayers. Colgan S. P., Parkos C. A., Bacarra A. E. and Madara J. L., pp. 993-994. M24.4. Myeloid blind panel mAb activate the NADPH oxidase pathway and alter triggering through high-affinity IgG-Fc receptors. Pfefferforn C. L. and Sylvester M. D., pp. 999-1001. M24.5. The effects of myeloid blind panel mAb on polymorphonuclear leukocyte phagocytosis. Malinowska I. and Buescher E. S., pp. 1001-1004. In: Leukocyte Typing V (Todd III R. F., Ed), 1995. Oxford University Press, Oxford.
12. M24.1. Influence of myeloid blind panel mAb on neutrophil transmigration across intestinal epithelial monolayers. Colgan S. P., Parkos C. A., Bacarra A. E. and Madara J. L., pp. 993-994. M24.4. Myeloid blind panel mAb activate the NADPH oxidase pathway and alter triggering through high-affinity IgG-Fc receptors. Pfefferforn C. L. and Sylvester M. D., pp. 999-1001. M24.5. The effects of myeloid blind panel mAb on polymorphonuclear leukocyte phagocytosis. Malinowska I. and Buescher E. S., pp. 1001-1004. In: Leukocyte Typing V (Todd III R. F., Ed), 1995. Oxford University Press, Oxford.
13. Vicari A.P., Bean A.G., Zlotnik A. Int. Immunol. 8:1996;183-191.
14. Okuyama Y., Ishihara K., Kimura N., Hirata Y., Sato K., Itoh M., Ok L.B., Hirano T. Biochem. Biophys. Res. Commun. 228:1996;838-845.
15. Shu S.Y., Chou T., Sakai K. J. Immunol. 143:1989;740-748.
16. Zheng X.M., Wang Y., Pallen C.J. Nature. 359:1992;336-339.
17. McNagny K.M., Cazenave P.A., Cooper M.D. J. Immunol. 141:1988;2551-2556.
18. McNagny K.M., Bucy R.P., Cooper M.D. Eur. J. Immunol. 21:1991;509-515.
19. Yarden Y., Schlessinger J. Biochemistry. 26:1987;1443-1451.
20. Ronnstrand L., Terracio L., Claesson-Welsh L., Heldin C.H., Rubin K. J. Biol. Chem. 263:1988;10429-10435.
21. Chen F., Weinberg R.A. Proc. Natl. Acad. Sci. USA. 92:1995;1565-1569.
22. Harris R.A., Eichholtz T.J., Hiles I.D., Page M.J., O'Hare M.J. Int. J. Cancer. 80:1999;477-484.
23. Burstein E.S., Spalding T.A., Brauner-Osborne H., Brann M.R. FEBS Lett. 363:1995;261-263.
24. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. Nature. 398:1999;252-256.
25. Mohammadi M., Honegger A., Sorokin A., Ullrich A., Schlessinger J., Hurwitz D.R. Biochemistry. 32:1993;8742-8748.
26. Boni-Schnetzler M., Pilch P.F. Proc. Natl. Acad. Sci. USA. 84:1987;7832-7836.
27. Spaargaren M., Defize L.H., de Laat S.W., Boonstra J. Biochem. Biophys. Res. Commun. 171:1990;882-889.
28. Cybulsky A.V., McTavish A.J., Cyr M.D. J. Clin. Invest. 94:1994;68-78.
29. McIntyre B.S., Birkenfeld H.P., Sylvester P.W. Cell Prolif. 28:1995;45-56.
30. Gulli L.F., Palmer K.C., Chen Y.Q., Reddy K.B. Cell Growth Differ. 7:1996;173-178.